A 2025 systematic review and meta-analysis in Reviews in Endocrine and Metabolic Disorders found that tirzepatide (the active ingredient in Mounjaro and Zepbound) reduced hsCRP by approximately 33% and IL-6 by approximately 18% compared to placebo across patients with and without diabetes. A growing body of research suggests this effect occurs through direct action on the NF-B pathway, a master switch of inflammation
It helps to assess the effectiveness and make necessary adjustments to dosage or lifestyle habits in consultation with a healthcare provider
It is well known that Serine (Ser) and Threonine (Thr) generally induce aggregation Tamas et al
CDC data sounds alarm over obesity Data for 2023 from the Centers for Disease Control and Prevention, released this September, found that in 23 states, more than 1 in 3 adults had obesity
To begin with, not everyone benefits from the medications
As important as GLP-1 drugs have become, we should be looking for the underlying cause